Abbott to acquire St Jude Medical

3rd May 2016

372

Abbott is set to acquire St Jude Medical, expanding its portfolio to cover cardiovascular markets such as atrial fibrillation, structural heart and heart failure as well as neuromodulation. The combined company will thus produce devices across cardiovascular, diabetes, vision and neuromodulation markets.

Miles D White, chairman and chief executive officer, Abbott, says, “The combined business will have a powerful pipeline ready to deliver next-generation medical technologies, and offer improved efficiencies for health care systems around the world.”

MultiPoint pacing technology using quadripolar technology, which is designed to provide additional options for cardiac resynchronisation therapy patients who are not responsive to other pacing options;